The MVP-5 system is used to reduce or obstruct blood flow for vessels between 3 and 5 mm in the peripheral vasculature.
More Articles on FDA Approvals:
FDA Approves Second Drug in Two Weeks to Treat Hepatitis C
4 Latest FDA Approvals
FDA Approves Linzess for Irritable Bowel Syndrome and Constipation
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
